Abstract

Tissue factor, the physiologic trigger of blood clotting, is the membrane-anchored protein cofactor for the plasma serine protease, factor VIIa. Tissue factor is hypothesized to position and align the active site of factor VIIa relative to the membrane surface for optimum proteolytic attack on the scissile bonds of membrane-bound protein substrates such as factor X. We tested this hypothesis by raising the factor VIIa binding site above the membrane surface by creating chimeras containing the tissue factor ectodomain linked to varying portions of the membrane-anchored protein, P-selectin. The tissue factor/P-selectin chimeras bound factor VIIa with high affinity and supported full allosteric activation of factor VIIa toward tripeptidyl-amide substrates. That the active site of factor VIIa was raised above the membrane surface when bound to tissue factor/P-selectin chimeras was confirmed using resonance energy transfer techniques in which appropriate fluorescent dyes were placed in the active site of factor VIIa and at the membrane surface. The chimeras were deficient in supporting factor X activation by factor VIIa due to decreased k(cat). The chimeras were also markedly deficient in clotting plasma, although incubating factor VII or VIIa with the chimeras prior to the addition of plasma restored much of their procoagulant activity. Interestingly, all chimeras fully supported tissue factor-dependent factor VII autoactivation. These studies indicate that proper positioning of the factor VII/VIIa binding site on tissue factor above the membrane surface is important for efficient rates of activation of factor X by this membrane-bound enzyme/cofactor complex.

Highlights

  • Tissue factor (TF)3 is the cell surface, type I integral membrane protein that triggers blood clotting in normal hemostasis and many thrombotic diseases [1, 2]

  • It has been hypothesized that an important role for membrane-bound cofactors such as TF is to factor VIIa (fVIIa), fVIIa in which the active site has been reacted with Fl-FPR-ck; factors X (fX), coagulation factor X; fIX, coagulation factor IX; Gla, ␥-carboxyglutamate; membTF, recombinant, membrane-anchored tissue factor (TF1–243); OR, octadecyl rhodamine; PC, phosphatidylcholine; PS, phosphatidylserine; PCPS, vesicles containing 80 mol % PC and 20 mol % PS; RET, resonance energy transfer; sTF, recombinant, soluble tissue factor (TF1–219); D, donoronly; DA, donor-acceptor

  • We investigated the importance of the role of TF in aligning the active site of fVIIa with the scissile bond of its membranebound macromolecular substrates by creating chimeric molecules in which the TF ectodomain was attached to a heterologous type I integral membrane protein, P-selectin

Read more

Summary

EXPERIMENTAL PROCEDURES

Materials—Materials were purchased from the following suppliers: pooled normal plasma, George King Bio-Medical (Overland Park, KS); chicken egg phosphatidylcholine (PC), porcine brain PS, and 1, 2 dioleoyl-sn-glycero-3-phosphocholine (DOPC), Avanti Polar Lipids (Alabaster, AL); Chromozym௡ t-PA, Roche Applied Science; S-2765, DiaPharma (West Chester, OH); Bio-Beads௡ SM-2 adsorbent, Bio-Rad; fluorescein-Phe-Pro-Arg chloromethylketone (Fl-FPR-ck), Hematologic Technologies (Essex Junction, VT); octadecyl rhodamine (OR), Invitrogen; octaethylene glycol monododecyl ether (C12E8), Fluka, and octyl-␤-D-glucopyranoside, Sigma; recombinant human fVIIa, American Diagnostica (Greenwich, CT); plasma-derived human fVII, fX, and fXa, Enzyme Research Laboratories (South Bend, IN); and HisTrapTM HP columns, GE Healthcare. For RET measurements, membTF or TF/P-selectin chimeras were incorporated into DOPC vesicles to avoid complications from Fl-FPR-fVIIa binding to PCPS vesicles in a TF-independent manner. RET Measurements—RET measurements were performed essentially as described [11] except that initial concentrations of Fl-FPR-fVIIa in the donor-only (D) and the donor-acceptor (DA) cuvettes were 6 nM in 50 mM Hepes (pH 7.4), 150 mM NaCl, 5 mM CaCl2. Reaction mixtures containing fVIIa and TF/PCPS in HBSAC were initiated by adding a mixture of fX and S-2765 substrate; change in A405 was monitored at ambient temperature, and initial rates of fX activation were determined by fitting a second-order polynomial to the A405 data as described [22]. Surface densities of membTF and TF/P-selectin molecules on the phospholipid vesicles varied from 3.7 ϫ 10Ϫ11 to 6.5 ϫ 10Ϫ10 mol mϪ2

RESULTS
97 Ϯ 11 110 Ϯ 17
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call